Suspension of Pharmacist for Misconduct, Including Unsupervised Medicine Supply and Fraudulent MUR Claims

Date of Decision: June 27, 2024

Registrant's Role: Pharmacist

Allegations:

  • Multiple instances of unsupervised medicine supply, failure to ensure controlled drug security, fraudulent Medicine Use Reviews (MURs), dishonest claims for payment, and record falsification.

Outcome: Suspension for 5 months

GPhC Standards Breached:

  • Standard 1.2 โ€“ Make sure that people can obtain medicines safely and ensure medicines are supplied under the supervision of a responsible pharmacist.
  • Standard 2.1 โ€“ Provide effective pharmacy services.
  • Standard 4.2 โ€“ Ensure the safety and quality of pharmacy services.
  • Standard 6.3 โ€“ Act with honesty and integrity to maintain public confidence in the profession.

Case Summary

The case involved a pharmacist who was the Responsible Pharmacist (RP), Superintendent Pharmacist (SI), and a director of a community pharmacy in Stockport between January 2018 and August 2019. Concerns were raised about his management practices, including the absence of a pharmacist from the premises during medicine supply, improper handling of controlled drugs, and submission of fraudulent Medicine Use Reviews (MURs) for financial gain.

Key Allegations and Findings:

    Continue Reading the Full Case

    Create a free account or log in to access the complete case summary.

    • Full allegations considered by the GPhC
    • Panel findings and reasoning
    • Outcome of the investigation
    • Sanctions considered and imposed on the Pharmacist
    • Key professional learning points

    Register for Free or Log In

    Original Case Document

    View the Full Determination Document

    The original determination transcript is available to registered users.

    • Download the official GPhC determination
    • Full hearing transcript
    • Detailed findings of fact
    • Sanction reasoning
    • Details of the pharmacy professionals involved

    Register for Free or Log In

    Leave a Reply